DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial
- PMID: 40764427
- PMCID: PMC12373023
- DOI: 10.1038/s41591-025-03823-3
DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial
Abstract
The Dietary Approaches to Stop Hypertension (DASH) diet is rich in foods (fruits, vegetables, whole grains) that may reduce hyperglycemia and glycemic variability. In this randomized crossover feeding trial, 89 participants with type 2 diabetes were fed four isocaloric diets in a random order: the DASH4D diet (a DASH-style diet tailored for diabetes) or a comparison (typical American) diet, each with higher (3,700 mg day-1 at 2,000 kcal) or lower (1,500 mg day-1 at 2,000 kcal) sodium. Each feeding period lasted 5 weeks. The primary outcomes were mean glucose; percentage of time spent with glucose between 70 and 180 mg dl-1 (time in range); and coefficient of variation assessed using 14 days of continuous glucose monitoring during each feeding period. The DASH4D (versus comparison) diet significantly reduced mean glucose (mean difference = -11.1 mg dl-1; P < 0.001), increased time in range (mean difference = +5.2 percentage points; P < 0.001) and had no effect on the coefficient of variation (P = 0.52). In analyses of secondary outcomes, glucose standard deviation and time spent with hyperglycemia (glucose >180 mg dl-1 and >250 mg dl-1) were lower in the DASH4D diet, but time spent with hypoglycemia (glucose <70 mg dl-1 and <54 mg dl-1) was similar across diets. There were no serious adverse events related to continuous glucose monitoring or the study diets. These results suggest that the DASH4D diet is a promising nutritional approach to substantially improve glycemic control in adults with type 2 diabetes. ClinicalTrials.gov registration: NCT04286555 .
© 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing interests: The authors declare no competing interests.
References
-
- UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837–853 (1998). - PubMed
-
- UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854–865 (1998). - PubMed
-
- Ohkubo Y, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes research and clinical practice 28, 103–117 (1995). - PubMed
Methods-only References
-
- ClinicalTrials.gov - DASH4D. Dietary Approaches to Stop Hypertension for Diabetes (DASH4D). (https://clinicaltrials.gov/study/NCT04286555?a=12, 2024).
-
- National Academies of Sciences E, et al. The National Academies Collection: Reports funded by National Institutes of Health. in Dietary Reference Intakes for Sodium and Potassium (eds. Oria M, Harrison M & Stallings VA) (National Academies Press, Washington DC, 2019). - PubMed
-
- U.S. Department of Agriculture, A.R.S. Nutrient Intakes from Food and Beverages: Mean Amounts Consumed per Individual, by Gender and Age, What We Eat in America, NHANES 2013–2014 (2016).
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
